BriaCell Therapeutics Corp. - Common Shares (BCTX) analyst actions
Rating and price-target actions on BCTX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the BCTX overview →
2 measured BCTX analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer | Press release | -1.66% | +5.30% | |
| Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing | Press release | -2.33% | -3.72% |
Keep exploring
More BCTX: earnings → · SEC filings → · BCTX overview →